TR 387 Mouse Pathology Tables
NTP STATISTICAL ANALYSIS OF PRIMARY TUMORS REPORT: PEIRPT08 LAB: Microbiological Assoc. DL AMPHETAMINE SULFATE DATE: 09/04/94 EXPERIMENT: 05029 TEST: 02 TIME: 12:43:13 TEST TYPE: CHRONIC CAGES FROM 0000 TO LAST CAGE PAGE: 1 CONT: N01CP9565001 ROUTE: DOSED FEED NTP C#: 55710 PATHOLOGIST: W. HALL S. EUSTIS CAS: 60-13-9 ------------------------------------------------------------------------------------------------------------------------------------ REASONS FOR REMOVAL: ALL REMOVAL DATE RANGE: ALL TREATMENT GROUPS: INCLUDE ALL NTP STATISTICAL ANALYSIS OF PRIMARY TUMORS REPORT: PEIRPT08 LAB: Microbiological Assoc. DL AMPHETAMINE SULFATE DATE: 09/04/94 EXPERIMENT: 05029 TEST: 02 TIME: 12:43:13 TEST TYPE: CHRONIC CAGES FROM 0000 TO LAST CAGE CONT: N01CP9565001 ROUTE: DOSED FEED NTP C#: 55710 PATHOLOGIST: W. HALL S. EUSTIS CAS: 60-13-9 MICE(B6C3F1) ---------------------------- FOR ALL DOSES THE TUMOR RATES IN THE FOLLOWING TISSUES/ORGANS ARE BASED ON NUMBER OF TISSUES EXAMINED. IN OTHER TISSUES/ORGANS, RATES ARE BASED ON NUMBER OF ANIMALS NECROPSIED. ---------------- Adrenal Gland Bone Marrow Brain Epididymis Gallbladder Heart Islets, Pancreatic Kidney Larynx Liver Lung Nose Ovary Pancreas Parathyroid Gland Pituitary Gland Preputial Gland Prostate Salivary Glands Spleen Testes Thymus Thyroid Gland Urinary Bladder NTP STATISTICAL ANALYSIS OF PRIMARY TUMORS REPORT: PEIRPT08 LAB: Microbiological Assoc. DL AMPHETAMINE SULFATE DATE: 09/04/94 EXPERIMENT: 05029 TEST: 02 TIME: 12:43:13 TEST TYPE: CHRONIC CAGES FROM 0000 TO LAST CAGE CONT: N01CP9565001 ROUTE: DOSED FEED NTP C#: 55710 PATHOLOGIST: W. HALL S. EUSTIS CAS: 60-13-9 SUMMARY OF STATISTICALLY SIGNIFICANT (P<=.05) RESULTS IN THE ANALYSIS OF THE STUDY OF DL AMPHETAMINE SULFATE ==================================================================================================== MALE MICE ------------- ORGAN MORPHOLOGY ------- ------------ Liver Hepatocellular Adenoma Hepatocellular Carcinoma or Hepatocellular Adenoma Hepatocellular Carcinoma, Hepatocellular Adenoma, or Hepatoblastoma All Organs Benign Tumors Malignant and Benign Tumors ==================================================================================================== FEMALE MICE ------------- ORGAN MORPHOLOGY ------- ------------ Harderian Gland Adenoma Lung Alveolar/Bronchiolar Adenoma Alveolar/Bronchiolar Carcinoma or Alveolar/Bronchiolar Adenoma Pituitary Gland: Pars Distalis or Unspecified Site Adenoma All Organs Benign Tumors Malignant Tumors Malignant and Benign Tumors ==================================================================================================== DATE: 09/04/94 EXPERIMENT: 05029 TEST: 02 PAGE 1 STATISTICAL ANALYSIS OF PRIMARY TUMORS IN MICE(B6C3F1) -- DL AMPHETAMINE SULFATE TERMINAL SACRIFICE AT 105 WEEKS |=================================================================================================================================| | | | | | | MALES | FEMALES | | | | | |DOSE | VEHICLE LOW M/F HIGH M/F | VEHICLE LOW M/F HIGH M/F | | | CONTROL 20PPM 100 PPM | CONTROL 20PPM 100 PPM | |=================================================================================================================================| | | |Adrenal Gland: Non-medullary, Non-cortical | | Adenoma | | | |---------------------------------------------------------------------------------------------------------------------------------| |TUMOR RATES | | | |----------- | | | |OVERALL (a) | 4/50 (8%) 1/49 (2%) 0/49 (0%) | 0/50 (0%) 0/46 (0%) 0/47 (0%) | |ADJUSTED (b) | 8.3% 2.1% 0.0% | 0.0% 0.0% 0.0% | |TERMINAL (d) | 4/48 (8%) 1/47 (2%) 0/48 (0%) | 0/35 (0%) 0/35 (0%) 0/41 (0%) | |FIRST INCIDENCE (DAYS) | 729 (T) 729 (T) --- | --- --- --- | |-----------------------| | | |STATISTICAL TESTS (f) | | | |-----------------------| | | |LIFE TABLE | P=0.070N P=0.187N P=0.064N | (e) (e) (e) | |INCIDENTAL TUMOR | P=0.070N P=0.187N P=0.064N | (e) (e) (e) | |LOGISTIC REGRESSION | P=0.070N P=0.187N P=0.064N | (e) (e) (e) | |COCHRAN-ARMITAGE | P=0.072N | (e) | |FISHER EXACT | P=0.187N P=0.061N | (e) (e) | |=================================================================================================================================| | | |Harderian Gland | | Adenoma | | | |---------------------------------------------------------------------------------------------------------------------------------| |TUMOR RATES | # # # | # # # | |----------- | | | |OVERALL (a) | 4/50 (8%) 2/50 (4%) 0/50 (0%) | 5/50 (10%) 2/50 (4%) 0/47 (0%) | |ADJUSTED (b) | 8.3% 4.2% 0.0% | 13.0% 5.6% 0.0% | |TERMINAL (d) | 4/48 (8%) 2/48 (4%) 0/49 (0%) | 3/35 (9%) 2/36 (6%) 0/41 (0%) | |FIRST INCIDENCE (DAYS) | 729 (T) 729 (T) --- | 632 732 (T) --- | |-----------------------| | | |STATISTICAL TESTS (f) | | | |-----------------------| | | |LIFE TABLE | P=0.060N P=0.337N P=0.061N | P=0.029N* P=0.212N P=0.027N* | |INCIDENTAL TUMOR | P=0.060N P=0.337N P=0.061N | P=0.047N* P=0.228N P=0.063N | |LOGISTIC REGRESSION | P=0.060N P=0.337N P=0.061N | P=0.040N* P=0.215N P=0.038N* | |COCHRAN-ARMITAGE | P=0.061N | P=0.042N* | |FISHER EXACT | P=0.339N P=0.059N | P=0.218N P=0.033N* | |=================================================================================================================================| DATE: 09/04/94 EXPERIMENT: 05029 TEST: 02 PAGE 2 STATISTICAL ANALYSIS OF PRIMARY TUMORS IN MICE(B6C3F1) -- DL AMPHETAMINE SULFATE TERMINAL SACRIFICE AT 105 WEEKS |=================================================================================================================================| | | | | | | MALES | FEMALES | | | | | |DOSE | VEHICLE LOW M/F HIGH M/F | VEHICLE LOW M/F HIGH M/F | | | CONTROL 20PPM 100 PPM | CONTROL 20PPM 100 PPM | |=================================================================================================================================| | | |Liver | | Hemangiosarcoma | | | |---------------------------------------------------------------------------------------------------------------------------------| |TUMOR RATES | | | |----------- | | | |OVERALL (a) | 3/50 (6%) 1/50 (2%) 1/50 (2%) | 0/50 (0%) 1/50 (2%) 0/47 (0%) | |ADJUSTED (b) | 6.3% 2.1% 2.0% | 0.0% 2.8% 0.0% | |TERMINAL (d) | 3/48 (6%) 1/48 (2%) 1/49 (2%) | 0/35 (0%) 1/36 (3%) 0/41 (0%) | |FIRST INCIDENCE (DAYS) | 729 (T) 729 (T) 729 (T) | --- 732 (T) --- | |-----------------------| | | |STATISTICAL TESTS (f) | | | |-----------------------| | | |LIFE TABLE | P=0.330N P=0.306N P=0.298N | P=0.650N P=0.506 (e) | |INCIDENTAL TUMOR | P=0.330N P=0.306N P=0.298N | P=0.650N P=0.506 (e) | |LOGISTIC REGRESSION | P=0.330N P=0.306N P=0.298N | P=0.650N P=0.506 (e) | |COCHRAN-ARMITAGE | P=0.337N | P=0.691N | |FISHER EXACT | P=0.309N P=0.309N | P=0.500 (e) | |=================================================================================================================================| | | |Liver | | Hepatocellular Adenoma | | | |---------------------------------------------------------------------------------------------------------------------------------| |TUMOR RATES | | | |----------- | | | |OVERALL (a) | 10/50 (20%) 7/50 (14%) 1/50 (2%) | 5/50 (10%) 1/50 (2%) 1/47 (2%) | |ADJUSTED (b) | 20.8% 14.3% 2.0% | 12.9% 2.6% 2.4% | |TERMINAL (d) | 10/48 (21%) 6/48 (13%) 1/49 (2%) | 3/35 (9%) 0/36 (0%) 1/41 (2%) | |FIRST INCIDENCE (DAYS) | 729 (T) 695 729 (T) | 579 704 732 (T) | |-----------------------| | | |STATISTICAL TESTS (f) | | | |-----------------------| | | |LIFE TABLE | P=0.005N** P=0.299N P=0.005N** | P=0.119N P=0.105N P=0.083N | |INCIDENTAL TUMOR | P=0.006N** P=0.207N P=0.005N** | P=0.218N P=0.114N P=0.162N | |LOGISTIC REGRESSION | P=0.005N** P=0.287N P=0.005N** | P=0.157N P=0.103N P=0.118N | |COCHRAN-ARMITAGE | P=0.005N** | P=0.157N | |FISHER EXACT | P=0.298N P=0.004N** | P=0.102N P=0.117N | |=================================================================================================================================| DATE: 09/04/94 EXPERIMENT: 05029 TEST: 02 PAGE 3 STATISTICAL ANALYSIS OF PRIMARY TUMORS IN MICE(B6C3F1) -- DL AMPHETAMINE SULFATE TERMINAL SACRIFICE AT 105 WEEKS |=================================================================================================================================| | | | | | | MALES | FEMALES | | | | | |DOSE | VEHICLE LOW M/F HIGH M/F | VEHICLE LOW M/F HIGH M/F | | | CONTROL 20PPM 100 PPM | CONTROL 20PPM 100 PPM | |=================================================================================================================================| | | |Liver | | Hepatocellular Carcinoma | | | |---------------------------------------------------------------------------------------------------------------------------------| |TUMOR RATES | | | |----------- | | | |OVERALL (a) | 4/50 (8%) 6/50 (12%) 1/50 (2%) | 0/50 (0%) 0/50 (0%) 0/47 (0%) | |ADJUSTED (b) | 8.3% 12.5% 2.0% | 0.0% 0.0% 0.0% | |TERMINAL (d) | 4/48 (8%) 6/48 (13%) 1/49 (2%) | 0/35 (0%) 0/36 (0%) 0/41 (0%) | |FIRST INCIDENCE (DAYS) | 729 (T) 729 (T) 729 (T) | --- --- --- | |-----------------------| | | |STATISTICAL TESTS (f) | | | |-----------------------| | | |LIFE TABLE | P=0.092N P=0.370 P=0.174N | (e) (e) (e) | |INCIDENTAL TUMOR | P=0.092N P=0.370 P=0.174N | (e) (e) (e) | |LOGISTIC REGRESSION | P=0.092N P=0.370 P=0.174N | (e) (e) (e) | |COCHRAN-ARMITAGE | P=0.096N | (e) | |FISHER EXACT | P=0.370 P=0.181N | (e) (e) | |=================================================================================================================================| | | |Liver | | Hepatocellular Carcinoma or Hepatocellular Adenoma | | | |---------------------------------------------------------------------------------------------------------------------------------| |TUMOR RATES | | | |----------- | | | |OVERALL (a) | 14/50 (28%) 12/50 (24%) 2/50 (4%) | 5/50 (10%) 1/50 (2%) 1/47 (2%) | |ADJUSTED (b) | 29.2% 24.5% 4.1% | 12.9% 2.6% 2.4% | |TERMINAL (d) | 14/48 (29%) 11/48 (23%) 2/49 (4%) | 3/35 (9%) 0/36 (0%) 1/41 (2%) | |FIRST INCIDENCE (DAYS) | 729 (T) 695 729 (T) | 579 704 732 (T) | |-----------------------| | | |STATISTICAL TESTS (f) | | | |-----------------------| | | |LIFE TABLE | P<0.001N** P=0.410N P=0.001N** | P=0.119N P=0.105N P=0.083N | |INCIDENTAL TUMOR | P<0.001N** P=0.322N P=0.001N** | P=0.218N P=0.114N P=0.162N | |LOGISTIC REGRESSION | P<0.001N** P=0.393N P=0.001N** | P=0.157N P=0.103N P=0.118N | |COCHRAN-ARMITAGE | P<0.001N** | P=0.157N | |FISHER EXACT | P=0.410N P<0.001N** | P=0.102N P=0.117N | |=================================================================================================================================| DATE: 09/04/94 EXPERIMENT: 05029 TEST: 02 PAGE 4 STATISTICAL ANALYSIS OF PRIMARY TUMORS IN MICE(B6C3F1) -- DL AMPHETAMINE SULFATE TERMINAL SACRIFICE AT 105 WEEKS |=================================================================================================================================| | | | | | | MALES | FEMALES | | | | | |DOSE | VEHICLE LOW M/F HIGH M/F | VEHICLE LOW M/F HIGH M/F | | | CONTROL 20PPM 100 PPM | CONTROL 20PPM 100 PPM | |=================================================================================================================================| | | |Liver | | Hepatocellular Carcinoma, Hepatocellular Adenoma, or Hepatoblastoma | | | |---------------------------------------------------------------------------------------------------------------------------------| |TUMOR RATES | | | |----------- | | | |OVERALL (a) | 14/50 (28%) 12/50 (24%) 2/50 (4%) | 5/50 (10%) 1/50 (2%) 1/47 (2%) | |ADJUSTED (b) | 29.2% 24.5% 4.1% | 12.9% 2.6% 2.4% | |TERMINAL (d) | 14/48 (29%) 11/48 (23%) 2/49 (4%) | 3/35 (9%) 0/36 (0%) 1/41 (2%) | |FIRST INCIDENCE (DAYS) | 729 (T) 695 729 (T) | 579 704 732 (T) | |-----------------------| | | |STATISTICAL TESTS (f) | | | |-----------------------| | | |LIFE TABLE | P<0.001N** P=0.410N P=0.001N** | P=0.119N P=0.105N P=0.083N | |INCIDENTAL TUMOR | P<0.001N** P=0.322N P=0.001N** | P=0.218N P=0.114N P=0.162N | |LOGISTIC REGRESSION | P<0.001N** P=0.393N P=0.001N** | P=0.157N P=0.103N P=0.118N | |COCHRAN-ARMITAGE | P<0.001N** | P=0.157N | |FISHER EXACT | P=0.410N P<0.001N** | P=0.102N P=0.117N | |=================================================================================================================================| | | |Lung | | Alveolar/Bronchiolar Adenoma | | | |---------------------------------------------------------------------------------------------------------------------------------| |TUMOR RATES | | | |----------- | | | |OVERALL (a) | 6/50 (12%) 2/50 (4%) 3/50 (6%) | 7/50 (14%) 4/50 (8%) 1/47 (2%) | |ADJUSTED (b) | 12.5% 4.2% 6.1% | 20.0% 11.1% 2.4% | |TERMINAL (d) | 6/48 (13%) 2/48 (4%) 3/49 (6%) | 7/35 (20%) 4/36 (11%) 1/41 (2%) | |FIRST INCIDENCE (DAYS) | 729 (T) 729 (T) 729 (T) | 732 (T) 732 (T) 732 (T) | |-----------------------| | | |STATISTICAL TESTS (f) | | | |-----------------------| | | |LIFE TABLE | P=0.321N P=0.135N P=0.233N | P=0.020N* P=0.241N P=0.018N* | |INCIDENTAL TUMOR | P=0.321N P=0.135N P=0.233N | P=0.020N* P=0.241N P=0.018N* | |LOGISTIC REGRESSION | P=0.321N P=0.135N P=0.233N | P=0.020N* P=0.241N P=0.018N* | |COCHRAN-ARMITAGE | P=0.332N | P=0.042N* | |FISHER EXACT | P=0.134N P=0.243N | P=0.262N P=0.036N* | |=================================================================================================================================| DATE: 09/04/94 EXPERIMENT: 05029 TEST: 02 PAGE 5 STATISTICAL ANALYSIS OF PRIMARY TUMORS IN MICE(B6C3F1) -- DL AMPHETAMINE SULFATE TERMINAL SACRIFICE AT 105 WEEKS |=================================================================================================================================| | | | | | | MALES | FEMALES | | | | | |DOSE | VEHICLE LOW M/F HIGH M/F | VEHICLE LOW M/F HIGH M/F | | | CONTROL 20PPM 100 PPM | CONTROL 20PPM 100 PPM | |=================================================================================================================================| | | |Lung | | Alveolar/Bronchiolar Carcinoma | | | |---------------------------------------------------------------------------------------------------------------------------------| |TUMOR RATES | | | |----------- | | | |OVERALL (a) | 3/50 (6%) 1/50 (2%) 1/50 (2%) | 1/50 (2%) 2/50 (4%) 0/47 (0%) | |ADJUSTED (b) | 6.3% 2.1% 2.0% | 2.9% 5.6% 0.0% | |TERMINAL (d) | 3/48 (6%) 1/48 (2%) 1/49 (2%) | 1/35 (3%) 2/36 (6%) 0/41 (0%) | |FIRST INCIDENCE (DAYS) | 729 (T) 729 (T) 729 (T) | 732 (T) 732 (T) --- | |-----------------------| | | |STATISTICAL TESTS (f) | | | |-----------------------| | | |LIFE TABLE | P=0.330N P=0.306N P=0.298N | P=0.258N P=0.510 P=0.468N | |INCIDENTAL TUMOR | P=0.330N P=0.306N P=0.298N | P=0.258N P=0.510 P=0.468N | |LOGISTIC REGRESSION | P=0.330N P=0.306N P=0.298N | P=0.258N P=0.510 P=0.468N | |COCHRAN-ARMITAGE | P=0.337N | P=0.310N | |FISHER EXACT | P=0.309N P=0.309N | P=0.500 P=0.515N | |=================================================================================================================================| | | |Lung | | Alveolar/Bronchiolar Carcinoma or Alveolar/Bronchiolar Adenoma | | | |---------------------------------------------------------------------------------------------------------------------------------| |TUMOR RATES | | | |----------- | | | |OVERALL (a) | 8/50 (16%) 3/50 (6%) 4/50 (8%) | 8/50 (16%) 6/50 (12%) 1/47 (2%) | |ADJUSTED (b) | 16.7% 6.3% 8.2% | 22.9% 16.7% 2.4% | |TERMINAL (d) | 8/48 (17%) 3/48 (6%) 4/49 (8%) | 8/35 (23%) 6/36 (17%) 1/41 (2%) | |FIRST INCIDENCE (DAYS) | 729 (T) 729 (T) 729 (T) | 732 (T) 732 (T) 732 (T) | |-----------------------| | | |STATISTICAL TESTS (f) | | | |-----------------------| | | |LIFE TABLE | P=0.253N P=0.101N P=0.169N | P=0.008N** P=0.361N P=0.009N** | |INCIDENTAL TUMOR | P=0.253N P=0.101N P=0.169N | P=0.008N** P=0.361N P=0.009N** | |LOGISTIC REGRESSION | P=0.253N P=0.101N P=0.169N | P=0.008N** P=0.361N P=0.009N** | |COCHRAN-ARMITAGE | P=0.264N | P=0.020N* | |FISHER EXACT | P=0.100N P=0.178N | P=0.387N P=0.019N* | |=================================================================================================================================| DATE: 09/04/94 EXPERIMENT: 05029 TEST: 02 PAGE 6 STATISTICAL ANALYSIS OF PRIMARY TUMORS IN MICE(B6C3F1) -- DL AMPHETAMINE SULFATE TERMINAL SACRIFICE AT 105 WEEKS |=================================================================================================================================| | | | | | | MALES | FEMALES | | | | | |DOSE | VEHICLE LOW M/F HIGH M/F | VEHICLE LOW M/F HIGH M/F | | | CONTROL 20PPM 100 PPM | CONTROL 20PPM 100 PPM | |=================================================================================================================================| | | |Mammary Gland | | Carcinoma or Adenoma | | | |---------------------------------------------------------------------------------------------------------------------------------| |TUMOR RATES | # # # | # # # | |----------- | | | |OVERALL (a) | 0/50 (0%) 0/50 (0%) 0/50 (0%) | 1/50 (2%) 2/50 (4%) 1/47 (2%) | |ADJUSTED (b) | 0.0% 0.0% 0.0% | 2.2% 5.6% 2.3% | |TERMINAL (d) | 0/48 (0%) 0/48 (0%) 0/49 (0%) | 0/35 (0%) 2/36 (6%) 0/41 (0%) | |FIRST INCIDENCE (DAYS) | --- --- --- | 632 732 (T) 708 | |-----------------------| | | |STATISTICAL TESTS (f) | | | |-----------------------| | | |LIFE TABLE | (e) (e) (e) | P=0.554N P=0.509 P=0.749N | |INCIDENTAL TUMOR | (e) (e) (e) | P=0.652 P=0.473 P=0.482 | |LOGISTIC REGRESSION | (e) (e) (e) | P=0.616N P=0.500 P=0.763 | |COCHRAN-ARMITAGE | (e) | P=0.616N | |FISHER EXACT | (e) (e) | P=0.500 P=0.737 | |=================================================================================================================================| | | |Mammary Gland | | Fibroma, Fibroadenoma, Carcinoma, or Adenoma | | | |---------------------------------------------------------------------------------------------------------------------------------| |TUMOR RATES | # # # | # # # | |----------- | | | |OVERALL (a) | 0/50 (0%) 0/50 (0%) 0/50 (0%) | 1/50 (2%) 2/50 (4%) 1/47 (2%) | |ADJUSTED (b) | 0.0% 0.0% 0.0% | 2.2% 5.6% 2.3% | |TERMINAL (d) | 0/48 (0%) 0/48 (0%) 0/49 (0%) | 0/35 (0%) 2/36 (6%) 0/41 (0%) | |FIRST INCIDENCE (DAYS) | --- --- --- | 632 732 (T) 708 | |-----------------------| | | |STATISTICAL TESTS (f) | | | |-----------------------| | | |LIFE TABLE | (e) (e) (e) | P=0.554N P=0.509 P=0.749N | |INCIDENTAL TUMOR | (e) (e) (e) | P=0.652 P=0.473 P=0.482 | |LOGISTIC REGRESSION | (e) (e) (e) | P=0.616N P=0.500 P=0.763 | |COCHRAN-ARMITAGE | (e) | P=0.616N | |FISHER EXACT | (e) (e) | P=0.500 P=0.737 | |=================================================================================================================================| DATE: 09/04/94 EXPERIMENT: 05029 TEST: 02 PAGE 7 STATISTICAL ANALYSIS OF PRIMARY TUMORS IN MICE(B6C3F1) -- DL AMPHETAMINE SULFATE TERMINAL SACRIFICE AT 105 WEEKS |=================================================================================================================================| | | | | | | MALES | FEMALES | | | | | |DOSE | VEHICLE LOW M/F HIGH M/F | VEHICLE LOW M/F HIGH M/F | | | CONTROL 20PPM 100 PPM | CONTROL 20PPM 100 PPM | |=================================================================================================================================| | | |Pituitary Gland: Pars Distalis or Unspecified Site | | Adenoma | | | |---------------------------------------------------------------------------------------------------------------------------------| |TUMOR RATES | | | |----------- | | | |OVERALL (a) | 0/48 (0%) 0/49 (0%) 0/50 (0%) | 12/49 (24%) 6/49 (12%) 1/46 (2%) | |ADJUSTED (b) | 0.0% 0.0% 0.0% | 32.2% 17.1% 2.3% | |TERMINAL (d) | 0/47 (0%) 0/47 (0%) 0/49 (0%) | 10/35 (29%) 6/35 (17%) 0/41 (0%) | |FIRST INCIDENCE (DAYS) | --- --- --- | 699 732 (T) 708 | |-----------------------| | | |STATISTICAL TESTS (f) | | | |-----------------------| | | |LIFE TABLE | (e) (e) (e) | P=0.001N** P=0.094N P<0.001N** | |INCIDENTAL TUMOR | (e) (e) (e) | P=0.002N** P=0.094N P=0.002N** | |LOGISTIC REGRESSION | (e) (e) (e) | P=0.001N** P=0.095N P=0.001N** | |COCHRAN-ARMITAGE | (e) | P=0.003N** | |FISHER EXACT | (e) (e) | P=0.096N P=0.001N** | |=================================================================================================================================| | | |Thyroid Gland: Follicular Cell | | Adenoma | | | |---------------------------------------------------------------------------------------------------------------------------------| |TUMOR RATES | | | |----------- | | | |OVERALL (a) | 0/50 (0%) 0/50 (0%) 2/50 (4%) | 1/50 (2%) 1/49 (2%) 1/47 (2%) | |ADJUSTED (b) | 0.0% 0.0% 4.1% | 2.9% 2.8% 2.4% | |TERMINAL (d) | 0/48 (0%) 0/48 (0%) 2/49 (4%) | 1/35 (3%) 1/36 (3%) 1/41 (2%) | |FIRST INCIDENCE (DAYS) | --- --- 729 (T) | 732 (T) 732 (T) 732 (T) | |-----------------------| | | |STATISTICAL TESTS (f) | | | |-----------------------| | | |LIFE TABLE | P=0.097 (e) P=0.243 | P=0.659N P=0.756N P=0.726N | |INCIDENTAL TUMOR | P=0.097 (e) P=0.243 | P=0.659N P=0.756N P=0.726N | |LOGISTIC REGRESSION | P=0.097 (e) P=0.243 | P=0.659N P=0.756N P=0.726N | |COCHRAN-ARMITAGE | P=0.094 | P=0.691 | |FISHER EXACT | (e) P=0.247 | P=0.747 P=0.737 | |=================================================================================================================================| DATE: 09/04/94 EXPERIMENT: 05029 TEST: 02 PAGE 8 STATISTICAL ANALYSIS OF PRIMARY TUMORS IN MICE(B6C3F1) -- DL AMPHETAMINE SULFATE TERMINAL SACRIFICE AT 105 WEEKS |=================================================================================================================================| | | | | | | MALES | FEMALES | | | | | |DOSE | VEHICLE LOW M/F HIGH M/F | VEHICLE LOW M/F HIGH M/F | | | CONTROL 20PPM 100 PPM | CONTROL 20PPM 100 PPM | |=================================================================================================================================| | | |Thyroid Gland: Follicular Cell | | Carcinoma or Adenoma | | | |---------------------------------------------------------------------------------------------------------------------------------| |TUMOR RATES | | | |----------- | | | |OVERALL (a) | 0/50 (0%) 1/50 (2%) 3/50 (6%) | 1/50 (2%) 1/49 (2%) 1/47 (2%) | |ADJUSTED (b) | 0.0% 2.1% 6.1% | 2.9% 2.8% 2.4% | |TERMINAL (d) | 0/48 (0%) 1/48 (2%) 3/49 (6%) | 1/35 (3%) 1/36 (3%) 1/41 (2%) | |FIRST INCIDENCE (DAYS) | --- 729 (T) 729 (T) | 732 (T) 732 (T) 732 (T) | |-----------------------| | | |STATISTICAL TESTS (f) | | | |-----------------------| | | |LIFE TABLE | P=0.084 P=0.500 P=0.125 | P=0.659N P=0.756N P=0.726N | |INCIDENTAL TUMOR | P=0.084 P=0.500 P=0.125 | P=0.659N P=0.756N P=0.726N | |LOGISTIC REGRESSION | P=0.084 P=0.500 P=0.125 | P=0.659N P=0.756N P=0.726N | |COCHRAN-ARMITAGE | P=0.080 | P=0.691 | |FISHER EXACT | P=0.500 P=0.121 | P=0.747 P=0.737 | |=================================================================================================================================| | | |Uterus | | Polyp Stromal | | | |---------------------------------------------------------------------------------------------------------------------------------| |TUMOR RATES | | # # # | |----------- | | | |OVERALL (a) | | 2/50 (4%) 1/50 (2%) 0/47 (0%) | |ADJUSTED (b) | | 5.2% 2.8% 0.0% | |TERMINAL (d) | | 1/35 (3%) 1/36 (3%) 0/41 (0%) | |FIRST INCIDENCE (DAYS) | | 686 732 (T) --- | |-----------------------| | | |STATISTICAL TESTS (f) | | | |-----------------------| | | |LIFE TABLE | | P=0.187N P=0.491N P=0.215N | |INCIDENTAL TUMOR | | P=0.239N P=0.493N P=0.320N | |LOGISTIC REGRESSION | | P=0.215N P=0.498N P=0.251N | |COCHRAN-ARMITAGE | | P=0.221N | |FISHER EXACT | | P=0.500N P=0.263N | |=================================================================================================================================| DATE: 09/04/94 EXPERIMENT: 05029 TEST: 02 PAGE 9 STATISTICAL ANALYSIS OF PRIMARY TUMORS IN MICE(B6C3F1) -- DL AMPHETAMINE SULFATE TERMINAL SACRIFICE AT 105 WEEKS |=================================================================================================================================| | | | | | | MALES | FEMALES | | | | | |DOSE | VEHICLE LOW M/F HIGH M/F | VEHICLE LOW M/F HIGH M/F | | | CONTROL 20PPM 100 PPM | CONTROL 20PPM 100 PPM | |=================================================================================================================================| | | |All Organs | | Hemangiosarcoma | | | |---------------------------------------------------------------------------------------------------------------------------------| |TUMOR RATES | # # # | # # # | |----------- | | | |OVERALL (a) | 4/50 (8%) 3/50 (6%) 1/50 (2%) | 1/50 (2%) 2/50 (4%) 0/47 (0%) | |ADJUSTED (b) | 8.3% 6.3% 2.0% | 2.9% 5.6% 0.0% | |TERMINAL (d) | 4/48 (8%) 3/48 (6%) 1/49 (2%) | 1/35 (3%) 2/36 (6%) 0/41 (0%) | |FIRST INCIDENCE (DAYS) | 729 (T) 729 (T) 729 (T) | 732 (T) 732 (T) --- | |-----------------------| | | |STATISTICAL TESTS (f) | | | |-----------------------| | | |LIFE TABLE | P=0.151N P=0.500N P=0.174N | P=0.258N P=0.510 P=0.468N | |INCIDENTAL TUMOR | P=0.151N P=0.500N P=0.174N | P=0.258N P=0.510 P=0.468N | |LOGISTIC REGRESSION | P=0.151N P=0.500N P=0.174N | P=0.258N P=0.510 P=0.468N | |COCHRAN-ARMITAGE | P=0.156N | P=0.310N | |FISHER EXACT | P=0.500N P=0.181N | P=0.500 P=0.515N | |=================================================================================================================================| | | |All Organs | | Hemangiosarcoma or Hemangioma | | | |---------------------------------------------------------------------------------------------------------------------------------| |TUMOR RATES | # # # | # # # | |----------- | | | |OVERALL (a) | 4/50 (8%) 3/50 (6%) 1/50 (2%) | 1/50 (2%) 2/50 (4%) 0/47 (0%) | |ADJUSTED (b) | 8.3% 6.3% 2.0% | 2.9% 5.6% 0.0% | |TERMINAL (d) | 4/48 (8%) 3/48 (6%) 1/49 (2%) | 1/35 (3%) 2/36 (6%) 0/41 (0%) | |FIRST INCIDENCE (DAYS) | 729 (T) 729 (T) 729 (T) | 732 (T) 732 (T) --- | |-----------------------| | | |STATISTICAL TESTS (f) | | | |-----------------------| | | |LIFE TABLE | P=0.151N P=0.500N P=0.174N | P=0.258N P=0.510 P=0.468N | |INCIDENTAL TUMOR | P=0.151N P=0.500N P=0.174N | P=0.258N P=0.510 P=0.468N | |LOGISTIC REGRESSION | P=0.151N P=0.500N P=0.174N | P=0.258N P=0.510 P=0.468N | |COCHRAN-ARMITAGE | P=0.156N | P=0.310N | |FISHER EXACT | P=0.500N P=0.181N | P=0.500 P=0.515N | |=================================================================================================================================| DATE: 09/04/94 EXPERIMENT: 05029 TEST: 02 PAGE 10 STATISTICAL ANALYSIS OF PRIMARY TUMORS IN MICE(B6C3F1) -- DL AMPHETAMINE SULFATE TERMINAL SACRIFICE AT 105 WEEKS |=================================================================================================================================| | | | | | | MALES | FEMALES | | | | | |DOSE | VEHICLE LOW M/F HIGH M/F | VEHICLE LOW M/F HIGH M/F | | | CONTROL 20PPM 100 PPM | CONTROL 20PPM 100 PPM | |=================================================================================================================================| | | |All Organs | | Histiocytic Sarcoma | | | |---------------------------------------------------------------------------------------------------------------------------------| |TUMOR RATES | # # # | # # # | |----------- | | | |OVERALL (a) | 0/50 (0%) 0/50 (0%) 0/50 (0%) | 2/50 (4%) 3/50 (6%) 0/47 (0%) | |ADJUSTED (b) | 0.0% 0.0% 0.0% | 5.7% 7.5% 0.0% | |TERMINAL (d) | 0/48 (0%) 0/48 (0%) 0/49 (0%) | 2/35 (6%) 1/36 (3%) 0/41 (0%) | |FIRST INCIDENCE (DAYS) | --- --- --- | 732 (T) 690 --- | |-----------------------| | | |STATISTICAL TESTS (f) | | | |-----------------------| | | |LIFE TABLE | (e) (e) (e) | P=0.124N P=0.517 P=0.204N | |INCIDENTAL TUMOR | (e) (e) (e) | P=0.192N P=0.508 P=0.204N | |LOGISTIC REGRESSION | (e) (e) (e) | P=0.151N P=0.503 P=0.204N | |COCHRAN-ARMITAGE | (e) | P=0.159N | |FISHER EXACT | (e) (e) | P=0.500 P=0.263N | |=================================================================================================================================| | | |All Organs | | Malignant Lymphoma And Histiocytic Sarcoma | | | |---------------------------------------------------------------------------------------------------------------------------------| |TUMOR RATES | # # # | # # # | |----------- | | | |OVERALL (a) | 4/50 (8%) 5/50 (10%) 5/50 (10%) | 17/50 (34%) 13/50 (26%) 10/47 (21%) | |ADJUSTED (b) | 8.3% 10.4% 10.0% | 39.2% 30.9% 22.6% | |TERMINAL (d) | 4/48 (8%) 5/48 (10%) 4/49 (8%) | 10/35 (29%) 8/36 (22%) 7/41 (17%) | |FIRST INCIDENCE (DAYS) | 729 (T) 729 (T) 624 | 519 495 555 | |-----------------------| | | |STATISTICAL TESTS (f) | | | |-----------------------| | | |LIFE TABLE | P=0.516 P=0.500 P=0.514 | P=0.068N P=0.256N P=0.062N | |INCIDENTAL TUMOR | P=0.539N P=0.500 P=0.632N | P=0.355N P=0.271N P=0.378N | |LOGISTIC REGRESSION | P=0.508 P=0.500 P=0.500 | P=0.136N P=0.257N P=0.120N | |COCHRAN-ARMITAGE | P=0.500 | P=0.138N | |FISHER EXACT | P=0.500 P=0.500 | P=0.257N P=0.121N | |=================================================================================================================================| DATE: 09/04/94 EXPERIMENT: 05029 TEST: 02 PAGE 11 STATISTICAL ANALYSIS OF PRIMARY TUMORS IN MICE(B6C3F1) -- DL AMPHETAMINE SULFATE TERMINAL SACRIFICE AT 105 WEEKS |=================================================================================================================================| | | | | | | MALES | FEMALES | | | | | |DOSE | VEHICLE LOW M/F HIGH M/F | VEHICLE LOW M/F HIGH M/F | | | CONTROL 20PPM 100 PPM | CONTROL 20PPM 100 PPM | |=================================================================================================================================| | | |All Organs | | Malignant Lymphoma: Histiocytic, Lymphocytic, Mixed, | | NOS, or Undifferentiated Cell Type | | | |---------------------------------------------------------------------------------------------------------------------------------| |TUMOR RATES | # # # | # # # | |----------- | | | |OVERALL (a) | 4/50 (8%) 5/50 (10%) 5/50 (10%) | 15/50 (30%) 10/50 (20%) 10/47 (21%) | |ADJUSTED (b) | 8.3% 10.4% 10.0% | 34.4% 24.7% 22.6% | |TERMINAL (d) | 4/48 (8%) 5/48 (10%) 4/49 (8%) | 8/35 (23%) 7/36 (19%) 7/41 (17%) | |FIRST INCIDENCE (DAYS) | 729 (T) 729 (T) 624 | 519 495 555 | |-----------------------| | | |STATISTICAL TESTS (f) | | | |-----------------------| | | |LIFE TABLE | P=0.516 P=0.500 P=0.514 | P=0.172N P=0.184N P=0.131N | |INCIDENTAL TUMOR | P=0.539N P=0.500 P=0.632N | P=0.573N P=0.192N P=0.589N | |LOGISTIC REGRESSION | P=0.508 P=0.500 P=0.500 | P=0.292N P=0.176N P=0.224N | |COCHRAN-ARMITAGE | P=0.500 | P=0.298N | |FISHER EXACT | P=0.500 P=0.500 | P=0.178N P=0.227N | |=================================================================================================================================| | | |All Organs | | Benign Tumors | | | |---------------------------------------------------------------------------------------------------------------------------------| |TUMOR RATES | # # # | # # # | |----------- | | | |OVERALL (a) | 23/50 (46%) 15/50 (30%) 9/50 (18%) | 30/50 (60%) 13/50 (26%) 5/47 (11%) | |ADJUSTED (b) | 47.9% 30.6% 18.4% | 71.1% 35.0% 11.9% | |TERMINAL (d) | 23/48 (48%) 14/48 (29%) 9/49 (18%) | 23/35 (66%) 12/36 (33%) 4/41 (10%) | |FIRST INCIDENCE (DAYS) | 729 (T) 695 729 (T) | 579 704 708 | |-----------------------| | | |STATISTICAL TESTS (f) | | | |-----------------------| | | |LIFE TABLE | P=0.004N** P=0.076N P=0.002N** | P<0.001N** P<0.001N** P<0.001N** | |INCIDENTAL TUMOR | P=0.004N** P=0.048N* P=0.002N** | P<0.001N** P<0.001N** P<0.001N** | |LOGISTIC REGRESSION | P=0.003N** P=0.065N P=0.002N** | P<0.001N** P<0.001N** P<0.001N** | |COCHRAN-ARMITAGE | P=0.005N** | P<0.001N** | |FISHER EXACT | P=0.074N P=0.002N** | P<0.001N** P<0.001N** | |=================================================================================================================================| DATE: 09/04/94 EXPERIMENT: 05029 TEST: 02 PAGE 12 STATISTICAL ANALYSIS OF PRIMARY TUMORS IN MICE(B6C3F1) -- DL AMPHETAMINE SULFATE TERMINAL SACRIFICE AT 105 WEEKS |=================================================================================================================================| | | | | | | MALES | FEMALES | | | | | |DOSE | VEHICLE LOW M/F HIGH M/F | VEHICLE LOW M/F HIGH M/F | | | CONTROL 20PPM 100 PPM | CONTROL 20PPM 100 PPM | |=================================================================================================================================| | | |All Organs | | Malignant Tumors | | | |---------------------------------------------------------------------------------------------------------------------------------| |TUMOR RATES | # # # | # # # | |----------- | | | |OVERALL (a) | 13/50 (26%) 17/50 (34%) 9/50 (18%) | 19/50 (38%) 17/50 (34%) 11/47 (23%) | |ADJUSTED (b) | 27.1% 35.4% 18.0% | 43.1% 40.8% 24.4% | |TERMINAL (d) | 13/48 (27%) 17/48 (35%) 8/49 (16%) | 11/35 (31%) 12/36 (33%) 7/41 (17%) | |FIRST INCIDENCE (DAYS) | 729 (T) 729 (T) 624 | 519 495 555 | |-----------------------| | | |STATISTICAL TESTS (f) | | | |-----------------------| | | |LIFE TABLE | P=0.103N P=0.256 P=0.220N | P=0.033N* P=0.396N P=0.045N* | |INCIDENTAL TUMOR | P=0.061N P=0.256 P=0.151N | P=0.235N P=0.427N P=0.364N | |LOGISTIC REGRESSION | P=0.100N P=0.256 P=0.217N | P=0.078N P=0.420N P=0.091N | |COCHRAN-ARMITAGE | P=0.114N | P=0.078N | |FISHER EXACT | P=0.257 P=0.235N | P=0.418N P=0.091N | |=================================================================================================================================| | | |All Organs | | Malignant and Benign Tumors | | | |---------------------------------------------------------------------------------------------------------------------------------| |TUMOR RATES | # # # | # # # | |----------- | | | |OVERALL (a) | 30/50 (60%) 25/50 (50%) 18/50 (36%) | 40/50 (80%) 27/50 (54%) 15/47 (32%) | |ADJUSTED (b) | 62.5% 51.0% 36.0% | 85.0% 65.5% 33.3% | |TERMINAL (d) | 30/48 (63%) 24/48 (50%) 17/49 (35%) | 28/35 (80%) 22/36 (61%) 11/41 (27%) | |FIRST INCIDENCE (DAYS) | 729 (T) 695 624 | 519 495 555 | |-----------------------| | | |STATISTICAL TESTS (f) | | | |-----------------------| | | |LIFE TABLE | P=0.012N* P=0.211N P=0.011N* | P<0.001N** P=0.012N* P<0.001N** | |INCIDENTAL TUMOR | P=0.007N** P=0.153N P=0.006N** | P<0.001N** P=0.005N** P<0.001N** | |LOGISTIC REGRESSION | P=0.010N** P=0.182N P=0.009N** | P<0.001N** P=0.005N** P<0.001N** | |COCHRAN-ARMITAGE | P=0.014N* | P<0.001N** | |FISHER EXACT | P=0.211N P=0.014N* | P=0.005N** P<0.001N** | |=================================================================================================================================| DATE: 09/04/94 EXPERIMENT: 05029 TEST: 02 PAGE 13 STATISTICAL ANALYSIS OF PRIMARY TUMORS IN MICE(B6C3F1) -- DL AMPHETAMINE SULFATE TERMINAL SACRIFICE AT 105 WEEKS (a) Number of tumor-bearing animals / number of animals examined at site. (b) Kaplan-Meier estimated lifetime tumor incidence after adjustment for intercurrent mortality. (d) Observed incidence at terminal kill. (f) Beneath the control incidence are the P-values associated with the trend test. Beneath the dosed group incidence are the P-values corresponding to pairwise comparisons between the controls and that dosed group. The life table analysis regards tumors in animals dying prior to terminal kill as being (directly or indirectly) the cause of death. The incidental tumor test regards these lesions as non-fatal. Logistic regression is an alternative method for analyzing the incidence of non-fatal tumors. The Cochran-Armitage and Fisher's exact tests compare directly the overall incidence rates. For all tests, a negative trend is indicated by "N". (e) Value of Statistic cannot be computed. (I) Interim sacrifice (T) Terminal sacrifice # Tumor rates based on number of animals necropsied. * To the right of any statistical result, indicates significance at (P<=0.05). ** To the right of any statistical result, indicates significance at (P<=0.01). --multipart-boundary Content-type: text/plain Range: bytes 89439-89439/89439 --multipart-boundary--